NCT05325034 Guideline Oriented Approach To Lipid Lowering In Asia-Pacific
| NCT ID | NCT05325034 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stephen Nicholls |
| Condition | Cardiovascular Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2022-09-15 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,000 participants in total. It began in 2022-09-15 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multinational, patient-level randomised, multi-phase standard-of-care control arm, parallel group, implementation study. Patients will be recruited during hospitalisation and be randomised to a multifaceted intervention to be delivered either 'early' (baseline) or 'late' (6 months), in a 1:1 fashion.
Eligibility Criteria
Inclusion Criteria: * 18 years of age * Admission for Type I myocardial infarction Exclusion Criteria: * LDL \<1.4mmol/L at baseline * Unable to provide contact details of primary care physician/general practitioner * Unable to provide written informed consent. * Unlikely to survive \>12 months
Contact & Investigator
Stephen Nicholls, MBBS, PhD
PRINCIPAL INVESTIGATOR
Monash University
Frequently Asked Questions
Who can join the NCT05325034 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cardiovascular Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05325034 currently recruiting?
Yes, NCT05325034 is actively recruiting participants. Contact the research team at julie.butters@monash.edu for enrollment information.
Where is the NCT05325034 trial being conducted?
This trial is being conducted at Wollongong, Australia, Cairns, Australia, Bedford Park, Australia, Clayton, Australia and 11 additional locations.
Who is sponsoring the NCT05325034 clinical trial?
NCT05325034 is sponsored by Stephen Nicholls. The principal investigator is Stephen Nicholls, MBBS, PhD at Monash University. The trial plans to enroll 2,000 participants.